Cardiome Provides U.S. Regulatory Update For BRINAVESS
Go back to Cardiome Provides U.S. Regulatory Update For BRINAVESS| Impreso, Inc. (NYSE: COM) | Delayed: 35.51 +0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.50 | 52 Week High | $0.60 | |||
| Open | $35.55 | 52 Week Low | $0.60 | |||
| Day High | $35.66 | P/E | N/A | |||
| Day Low | $35.42 | EPS | $-0.26 | |||
| Volume | 95,962 | |||||
| CARDIOME PHARMA (NASDAQ: CRME) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $9.21 | |||
| Open | $28.95 | 52 Week Low | $2.35 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $0.00 | |||
| Volume | 525 | |||||
